{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:44Z","timestamp":1793600864544,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabres.2026.113191","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:19:34Z","timestamp":1771949974000},"page":"113191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of metformin on the risk of osteoarthritis in patients with type 2 diabetes: a real-world study"],"prefix":"10.1016","volume":"235","author":[{"given":"Shengwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaJun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.diabres.2026.113191_b0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"issue":"10182","key":"10.1016\/j.diabres.2026.113191_b0010","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.diabres.2026.113191_b0015","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp Mol Med"},{"issue":"10158","key":"10.1016\/j.diabres.2026.113191_b0020","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(18)32344-4","article-title":"Knee replacement","volume":"392","author":"Price","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2026.113191_b0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.diabres.2026.113191_b0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2337\/dc12-0740","article-title":"The use of metformin and the incidence of lung cancer in patients with type 2 diabetes","volume":"36","author":"Smiechowski","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2026.113191_b0035","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113191_b0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jare.2024.04.012","article-title":"Interplay between lipid dysregulation and ferroptosis in chondrocytes and the targeted therapy effect of metformin on osteoarthritis","volume":"69","author":"Zou","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.diabres.2026.113191_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121092","article-title":"Metformin suppresses oxidative stress induced by high glucose via activation of the Nrf2\/HO-1 signaling pathway in type 2 diabetic osteoporosis","volume":"312","author":"Chen","year":"2023","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113191_b0050","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/rheumatology\/keac467","article-title":"Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes","volume":"62","author":"Li","year":"2023","journal-title":"Rheumatology"},{"issue":"49","key":"10.1016\/j.diabres.2026.113191_b0055","doi-asserted-by":"crossref","first-page":"E1672","DOI":"10.1503\/cmaj.220952","article-title":"Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study","volume":"194","author":"Zhu","year":"2022","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.diabres.2026.113191_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3646","article-title":"Development of osteoarthritis in adults with type 2 diabetes treated with metformin vs a sulfonylurea","volume":"6","author":"Baker","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.diabres.2026.113191_b0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diabet.2018.08.008","article-title":"Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study","volume":"45","author":"Liu","year":"2019","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113191_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-021-02191-2","article-title":"Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors","volume":"20","author":"Kovesdy","year":"2022","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.diabres.2026.113191_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009952","article-title":"Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations","volume":"6","author":"Khokhar","year":"2016","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.diabres.2026.113191_b0080","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","article-title":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome","volume":"60","author":"Sam","year":"2017","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.diabres.2026.113191_b0085","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.41412","article-title":"Reduction in osteoarthritis risk after treatment with ticagrelor compared to clopidogrel: a propensity score-matching analysis","volume":"72","author":"Baker","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.diabres.2026.113191_b0090","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1302\/0301-620X.104B9.BJJ-2022-0013.R1","article-title":"Temporal trends in comorbidity in adult elective hip and knee arthroplasty patients in England : a national population-based cohort study from the National Joint Registry","volume":"104-B","author":"Penfold","year":"2022","journal-title":"Bone Joint J"},{"issue":"1","key":"10.1016\/j.diabres.2026.113191_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-0859.R1","article-title":"Impact of comorbidities on the safety and effectiveness of hip and knee arthroplasty surgery","volume":"103-B","author":"Podmore","year":"2021","journal-title":"Bone Joint J"},{"issue":"5","key":"10.1016\/j.diabres.2026.113191_b0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Journal of chronic diseases"},{"issue":"5","key":"10.1016\/j.diabres.2026.113191_b0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"S3","key":"10.1016\/j.diabres.2026.113191_b0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/dom.15729","article-title":"Clinical efficacy and cost-effectiveness of metformin in different patient populations: a narrative review of real-world evidence","volume":"26","author":"Solini","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.diabres.2026.113191_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11892-024-01539-1","article-title":"Metformin: past, present, and future","volume":"24","author":"Chaudhary","year":"2024","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.diabres.2026.113191_b0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwv445","article-title":"Adverse effects of beta-interferon for multiple sclerosis study G. Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies","volume":"184","author":"Karim","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113191_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"25","key":"10.1016\/j.diabres.2026.113191_b0130","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113191_b0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113191_b0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.42307","article-title":"Association of decrease in body mass index with reduced incidence and progression of the structural defects of knee osteoarthritis: a prospective multi-cohort study","volume":"75","author":"Salis","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.diabres.2026.113191_b0145","article-title":"Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health","volume":"16\u20132025","author":"Halabitska","year":"2025","journal-title":"Front Pharmacol"},{"issue":"20","key":"10.1016\/j.diabres.2026.113191_b0150","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/jama.2025.3471","article-title":"Metformin for knee osteoarthritis in patients with overweight or obesity: a randomized clinical trial","volume":"333","author":"Pan","year":"2025","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113191_b0155","unstructured":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet 2024; 404(10467): 2077-93."},{"key":"10.1016\/j.diabres.2026.113191_b0160","unstructured":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Rheumatology 2023; 5(9): e508-e22."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:57Z","timestamp":1793598117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"alternative-id":["S0168822726001105"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113191","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of metformin on the risk of osteoarthritis in patients with type 2 diabetes: a real-world study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113191"}}